bg
I

Immunitybio (IBRX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Immunitybio (IBRX)

Immunitybio, Inc., formerly NantKwest, Inc., is a late-clinical-stage immunotherapy company developing therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The Company’s immunotherapy platform activates both the ... Read more

  • USD5.41
  • USD5.82
  • USD5.35
  • USD6.93
  • 19.00%
  • 1M
  • 2.57M
  • 4.23M
  • 4.1B
  • 1.25
  • 219.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.